CN101337033A - Canine parvovirus resisting preparation - Google Patents
Canine parvovirus resisting preparation Download PDFInfo
- Publication number
- CN101337033A CN101337033A CNA2007100153632A CN200710015363A CN101337033A CN 101337033 A CN101337033 A CN 101337033A CN A2007100153632 A CNA2007100153632 A CN A2007100153632A CN 200710015363 A CN200710015363 A CN 200710015363A CN 101337033 A CN101337033 A CN 101337033A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- canine parvovirus
- preparation
- canine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an anti-canine parvovinis disease preparation which is characterized in that the preparation is prepared by the weight part from 25 to 35 parts of lalang grass rhizome, 25 to 35 parts of ailanthus altissima swingle, 30 to 40 parts of liquiritia glycyrrhiza, 40 to 60 parts of radix isatidis, 40 to 60 parts of baical skullcap root and 30 to 50 parts of pulsatilla chinensis, and has comparatively significant effect of curing the canine parvovinis viral enteritis.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of the Canine Parvovirus enteritis, belong to pure Chinese herbal medicine.
Background technology
The canine parvovirus disease enteritis is a kind of deadly infectious disease with height contagious infection that is caused dog by Canine Parvovirus.The mortality rate height.Mainly propagate by digestive tract.The source of infection mainly is ill dog and is with malicious dog.With frequent vomiting, hemorrhagic diarrhea and rapid dehydration is classical symptom, two types of clinical manifestation hemorrhagic enteritis and apyetous myocarditis.The dog at various ages is PI all, and is the highest with 3-6 month dog susceptible rate.The medicine, particularly Chinese patent medicine of existing treatment canine parvovirus disease enteritis are very few, and curative effect is not remarkable, and cure rate is low, and mortality rate is very high, and pup is up to 50-100%.
Summary of the invention
The present invention is intended to improve above-mentioned deficiency, and a kind of canine parvovirus resisting preparation is provided, and by selecting suitable Chinese medicine and consumption proportion thereof, reaches the significant purpose of therapeutic effect.
In order to achieve the above object, the present invention is achieved in that
A kind of Chinese medicine for the treatment of the canine parvovirus disease enteritis is characterized in that: get Rhizoma Imperatae 25-35 part, and Fructus Ailanthi 25-35 part, Radix Glycyrrhizae 30-40 part, Radix Isatidis 40-60 part, Radix Scutellariae 40-60 part, Radix Pulsatillae 30-50 part is formulated; Described part refers to weight portion.
Preferred prescription is: 30 parts of Rhizoma Imperataes, 30 parts of Fructus Ailanthi, 35 parts in Radix Glycyrrhizae, 50 parts of Radix Isatidis, 50 parts of Radix Scutellariaes, 40 parts of the Radix Pulsatillaes.
Chinese herbal medicine of the present invention is according to traditional medicine and modern medicine analysis, and the property of medicine and pharmacological action are as follows.
Rhizoma Imperatae: cold; Sweet; Return lung, stomach, urinary bladder channel.Cooling blood for hemostasis, clearing away heat and promoting diuresis.Be used for heat in blood and spit blood epistaxis, hematuria, calentura excessive thirst, jaundice, edema, the puckery pain of pyretic stranguria, acute nephritis edema.
Fructus Ailanthi: bitter, puckery, cold.Go into stomach, large intestine channel.Heat clearing and damp drying, relieving diarrhea with astringents, leukorrhagia stopping, hemostasis.
Radix Glycyrrhizae: sweet in the mouth is flat.With middle emergency, lung moistening, detoxifcation, coordinating the actions of various ingredients in a prescription.Control weakness of the spleen and stomach, lack of appetite, stomachache loose stool, overstrain heating, consumptive lung disease cough, cardiopalmus, infantile convulsion; Give birth to usefulness, control laryngopharynx swelling and pain, peptic ulcer, ulcer sores is separated poison of drug and alimentary toxicosis.
Radix Isatidis: cold; Bitter; GUIXIN, stomach warp.Heat-clearing and toxic substances removing, the removing heat from blood sore-throat relieving.Be used for maculae caused by violent heat pathogen, tongue falls purple dark, mumps, sore throat, mashed watchtower in ancient times scarlet fever, major part pestilence, carbuncle, erysipelas.
Radix Scutellariae: cold; Bitter; Return lung, gallbladder, spleen, large intestine, small intestine meridian.Heat clearing and damp drying, eliminating fire and detoxication, hemostasis, antiabortive.Be used for hygropyrexia, fever disease in summer vomiting and nausea uncomfortable in chest, damp and hot feeling of fullness, dysentery, jaundice, the cough due to lung-heat, the hyperpyrexia excessive thirst, heat in blood is told nosebleed, carbuncle sore tumefacting virus, frequent fetal movement.
The Radix Pulsatillae: cold; Bitter; Return stomach, large intestine channel.Heat-clearing and toxic substances removing, eliminating pathogenic heat from blood to cure dysentery.Be used for toxic-heat and blood stasis, pudendal pruritus leukorrhagia, amebic dysentery.
The present invention sheerly prepared from traditional Chinese medicines forms, and is a kind of Chinese medicine for oral administration.Treatment canine parvovirus disease enteritis effect is apparent in view.
The specific embodiment
In order to understand better and to implement, further specify the present invention below in conjunction with embodiment.
Embodiment one
Get 25 parts of Rhizoma Imperataes, 25 parts of Fructus Ailanthi, 30 parts in Radix Glycyrrhizae, 40 parts of Radix Isatidis, 40 parts of Radix Scutellariaes in 30 parts of adding containers of the Radix Pulsatillae, added water logging 1 hour, and intense fire is heated to and boils, slow fire heating 30 minutes.Be chilled to room temperature, filtered through gauze is drawn 100 parts of filtrates with the large size needle tubing, gavages from sick dog oral area.Continuous 3-5 day.
Embodiment two
30 parts of Rhizoma Imperataes, 30 parts of Fructus Ailanthi, 35 parts in Radix Glycyrrhizae, 50 parts of Radix Isatidis, 50 parts of Radix Scutellariaes in 40 parts of adding containers of the Radix Pulsatillae, added water logging 1 hour, and intense fire is heated to and boils, slow fire heating 30 minutes.Be chilled to room temperature, filtered through gauze is drawn 100 parts of filtrates with the large size needle tubing, gavages from sick dog oral area.Continuous 3-5 day.
Embodiment three
Get 35 parts of Rhizoma Imperataes, 35 parts of Fructus Ailanthi, 40 parts in Radix Glycyrrhizae, 60 parts of Radix Isatidis, 60 parts of Radix Scutellariaes in 50 parts of adding containers of the Radix Pulsatillae, added water logging 1 hour, and intense fire is heated to and boils, slow fire heating 30 minutes.Be chilled to room temperature, filtered through gauze is drawn 100 parts of filtrates with the large size needle tubing, gavages from sick dog oral area.Continuous 3-5 day.
It below is clinical use curative effect situation.
With medicine treatment canine parvovirus disease enteritis 20 examples of the present invention, the result shows medicine group obvious effective rate 90% of the present invention, total effective rate 95%.
Claims (2)
1, a kind of canine parvovirus resisting preparation is characterized in that: get Rhizoma Imperatae 25-35 part, and Fructus Ailanthi 25-35 part, Radix Glycyrrhizae 30-40 part, Radix Isatidis 40-60 part, Radix Scutellariae 40-60 part, Radix Pulsatillae 30-50 part is formulated; Described part refers to weight portion.
2, according to the described canine parvovirus resisting preparation of claim 1, it is characterized in that: 30 parts of Rhizoma Imperataes, 30 parts of Fructus Ailanthi, 35 parts in Radix Glycyrrhizae, 50 parts of Radix Isatidis, 50 parts of Radix Scutellariaes, 40 parts of the Radix Pulsatillaes are formulated.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100153632A CN101337033A (en) | 2007-07-08 | 2007-07-08 | Canine parvovirus resisting preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100153632A CN101337033A (en) | 2007-07-08 | 2007-07-08 | Canine parvovirus resisting preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101337033A true CN101337033A (en) | 2009-01-07 |
Family
ID=40211298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007100153632A Pending CN101337033A (en) | 2007-07-08 | 2007-07-08 | Canine parvovirus resisting preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101337033A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101564524B (en) * | 2009-06-05 | 2011-03-16 | 中国人民解放军军事医学科学院军事兽医研究所 | Traditional Chinese medicine injection for treating canine parvovirus disease and preparation method thereof |
| CN101537059B (en) * | 2009-04-20 | 2011-05-25 | 西南大学 | Anti-enteritis canine parvovirus Chinese medicinal composition and preparation method and applications thereof |
| WO2019149155A1 (en) * | 2018-01-31 | 2019-08-08 | 四川英路维特医药科技有限公司 | Uses of pulsatilla chinensis extract in preparing drug for treating viral and/or bacterial diseases |
-
2007
- 2007-07-08 CN CNA2007100153632A patent/CN101337033A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101537059B (en) * | 2009-04-20 | 2011-05-25 | 西南大学 | Anti-enteritis canine parvovirus Chinese medicinal composition and preparation method and applications thereof |
| CN101564524B (en) * | 2009-06-05 | 2011-03-16 | 中国人民解放军军事医学科学院军事兽医研究所 | Traditional Chinese medicine injection for treating canine parvovirus disease and preparation method thereof |
| WO2019149155A1 (en) * | 2018-01-31 | 2019-08-08 | 四川英路维特医药科技有限公司 | Uses of pulsatilla chinensis extract in preparing drug for treating viral and/or bacterial diseases |
| JP2021512880A (en) * | 2018-01-31 | 2021-05-20 | スーチュワン インル ウェイトー ファーマスーティカル テクノロジー カンパニー リミテッド | Use of Bulbul extract in the manufacture of drugs to treat viral and / or bacterial diseases |
| JP7021360B2 (en) | 2018-01-31 | 2022-02-16 | スーチュワン インル ウェイトー ファーマスーティカル テクノロジー カンパニー リミテッド | Use of light-vented bulbul extract in the manufacture of drugs to treat viral and / or bacterial diseases |
| US11510933B2 (en) | 2018-01-31 | 2022-11-29 | Sichuan Inlu Weite Pharmaceutical Technology Co., Ltd. | Use of Pulsatilla chinensis extract in the preparation of drugs for treatment of viral and/or bacterial diseases |
| AU2019214081B2 (en) * | 2018-01-31 | 2023-11-23 | Sichuan Inlu Weite Pharmaceutical Technology Co., Ltd. | Uses of Pulsatilla chinensis extract in preparing drug for treating viral and/or bacterial diseases |
| AU2019214082B2 (en) * | 2018-01-31 | 2023-11-30 | Sichuan Inlu Weite Pharmaceutical Technology Co., Ltd. | Uses of Pulsatilla Chinensis extract in preparing drug for treating viral and/or bacterial diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101618155B (en) | Medicine for curing oral mucosal disease | |
| CN101530602A (en) | Traditional Chinese medicine for treating swine fever | |
| CN102552697B (en) | Chinese medicinal preparation for treating hand-foot-mouth disease | |
| CN101380448A (en) | Traditional Chinese medicine for preventing and treating pig influenza | |
| CN100594035C (en) | Chinese medicine compound oral administration for treating gastric ulcer | |
| CN104147508A (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
| CN102451459A (en) | Chinese medicine for treating fowl plague | |
| CN103920074A (en) | Traditional Chinese medicine composition for treating hepatitis B | |
| CN101337033A (en) | Canine parvovirus resisting preparation | |
| CN101337054A (en) | Canine parvovirus prevention preparation | |
| CN100579563C (en) | Oral Chinese medicine composition for treating bronchiolectasis | |
| CN103127351B (en) | Traditional Chinese medicine for treating premature menstruation | |
| CN102600391B (en) | Traditional Chinese medicine composition for treating pediatric acute tonsillitis | |
| CN104547048A (en) | Chinese herbal medicine compound preparation for preventing and treating infantile hand-foot-mouth disease and preparation method thereof | |
| CN102133369B (en) | Traditional Chinese medicine composition for treating acute cholecystitis | |
| CN101085265A (en) | Traditional Chinese medicine for treating urinary tract infection | |
| CN103536721A (en) | Traditional Chinese medicine for treating chronic nasosinusitis | |
| CN101554421A (en) | Traditional Chinese medicine formula for curing acute appendicitis | |
| CN101401876B (en) | Chinese medicinal composition for treating upper respiratory tract infection | |
| CN101249204B (en) | Pulmonary tuberculosis treating Chinese medicine | |
| CN101912488A (en) | Chinese medicinal herb for treating hypomenorrhea | |
| CN101700282A (en) | Traditional Chinese medicine for treating wind-cold rhinitis | |
| CN104721634A (en) | Chinese herbal preparation for herpangina and preparation method of Chinese herbal preparation for herpangina | |
| CN103705880A (en) | Traditional Chinese medicine preparation for treating pharyngitis | |
| CN102895555A (en) | Traditional Chinese medicine for treating mumps viral encephalopathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090107 |